item management s discussion and analysis of financial condition and results of operations except for historical information  statements relating to the company s plan  objectives and future performance are forward looking statements within the meaning of the private securities litigation reform act of such statements are based on management s current expectations 
because of various risks and uncertainties  actual strategies and results in future periods may differ materially from those currently expected 
the discussion set forth below analyzes certain factors and trends related to the financial results for each of the three years ended april   and this discussion should be read in conjunction with the consolidated financial statements and notes to the consolidated financial statements 
background the company was incorporated in delaware in and initially provided medical advertising and marketing services in the united states  primarily to ophthalmologists 
by  the company had shifted its strategic emphasis to the emerging ophthalmic technology based on the use of excimer lasers for prk and acquired an excimer laser for use in a clinical center as part of clinical trials with respect to the safety and efficacy of prk 
subsequent to the purchase of its first laser  the company determined that fda approval for prk in the united states would require a lengthier process than was originally anticipated 
as a result  the company decided to enter the international market for excimer laser surgery where regulatory restrictions were less prohibitive 
between late and mid  the company acquired three commercial excimer laser centers in canada and began developing the first mobilexcimer r unit 
in july  the company opened a fourth canadian center and purchased six excimer lasers installed in europe 
in april  the company acquired eight additional lasers installed in europe 
the first prk procedure on a mobilexcimer system was performed in ontario  canada in september in anticipation of the fda s approval of the excimer laser to perform prk procedures  in december the company restated its agreement with columbia hca healthcare corporation columbia pursuant to which the company became the primary provider of excimer lasers to columbia s ambulatory surgery centers 
in addition  by the fall of  the company extended testing of its mobilexcimer system to england  opened two european centers including a company owned center with an improved excimer laser system  acquired an additional mobilexcimer unit and selected dr 
richard lindstrom as the company s medical director 
in august  the company acquired vision correction  inc  an excimer laser access provider  for common stock with a value of approximately  in october and march  the fda approved the use of the excimer lasers manufactured by summit and visx  respectively  for performing prk procedures for low to moderate myopia  making it possible for the company to begin providing ophthalmologists access to excimer lasers in the united states 
during april  the company purchased assets from a former competitor to expand its european operations for a purchase price of approximately  including cash and assumed liabilities 
results of operations fiscal year ended april  compared to fiscal year ended april  during the year ended april   the company focused upon the development of the us market 
during the last quarter of fiscal the company began aggressively pursuing its mobile laser strategy in the us by redeploying several of its fixed site lasers utilizing its newly developed roll on roll off strategy 
revenues 
total revenues increased to  for the year ended april  from  for the year ended april   or an increase of revenues for the laservision centers division increased to  for the year ended april  from  for the year ended april  the increase in revenues is attributable to a  increase in us revenues and a  increase in european revenues 
the increase in us revenues for the laservision centers division is attributable primarily to the increased number of lasers in operation and procedures performed on each laser in the us the increase in european revenues is attributable to the increased procedures from the solihull and edinburgh centers acquired in the new image acquisition and increased procedures performed on the mobilexcimer 
revenues for the marketvision division decreased to  for the year ended april  from  for the year ended april  the  decrease in marketvision division revenues reflects the shift of attention to providing marketing services for the company s laser centers for which the company does not record revenue 
during the year ended april   revenues from the laservision centers division represented of total revenues versus for the year ended april  revenues from the marketvision division represented of total revenues during the year ended april  versus for the year ended april  costs of revenues gross profit loss 
cost of revenues increased to  for the year ended april  from  for the year ended april  this increase was primarily due to an increase in depreciation to  from  in these respective periods due to the increased inventory of lasers and other medical equipment 
excluding laser and medical equipment depreciation  all other costs of revenues increased by  this increase  when combined with the revenue increase  resulted in these other costs of revenues decreasing from of total revenues for the year ended april  to of total revenues for the year ended april  this  increase was primarily due to an increase of  in pillar point royalties   in professional medical services and  in gas costs on higher volumes of prk procedures and new centers 
total gross profit increased to a profit of  for the year ended april  from a loss of  for the year ended april  the variable gross profit  excluding depreciation  increased to  from  primarily due to higher volumes of prk procedures and centers 
operating expenses 
general and administrative expenses increased to  for the year ended april  from  for the year ended april  due to a  increase in legal  accounting and professional fees  a  increase in rent and other office expenses in the us market  a  increase in rent and other office expenses in the european market  a  increase in insurance expense   of development costs associated with a new mobile laser concept   of stock offering costs  and a net increase of  in other general and administrative expenses 
the increase in salaries and related expenses to  for the year ended april  from  for the year ended april  was due to an increase of  attributable to an increased number of employees  salary adjustments and the related payroll taxes and fringe benefits  partially offset by a  decrease in executive incentive compensation 
depreciation and amortization increased by  for the year ended april  primarily due to an increase in amortization of goodwill associated with acquisitions and a full year of depreciation for the corporate office opened in march the increase in selling and marketing expenses to  for the year ended april  from  for the year ended april  was due to an increase of  in us marketing  a  increase in european advertising and a  increase in canadian marketing 
due to recent improvements in excimer laser technology  international market conditions and the resulting operational considerations  the company believes that the recorded carrying value of certain of its international fixed site assets exceeded their estimated fair values 
accordingly  the company recorded a non cash impairment charge of approximately million in the fourth quarter of fiscal see note to consolidated financial statements 
loss from operations 
the laservision centers division s loss from operations increased to  for the year ended april  from  for the year ended april   due to increased costs related to commencing us operations  a  increase in total depreciation and amortization expenses  a  increase in variable costs of revenue and a  increase in operating costs other than depreciation 
the marketvision division s income from operations decreased to a loss of  for the year ended april  from  of income for the year ended april  primarily as a result of the shift in attention to providing marketing for the us laser vision centers for which the company does not record revenue 
the domestic loss from operations increased to  for the year ended april  from  for the year ended april  due to a million write down of lasers and related equipment  a million increase in the loss from us laser operations  and a  increase in payroll 
the canadian loss from operations decreased to  for the year ended april  from  for the year ended april  primarily due to a decrease of  in the write down of lasers and related medical equipment  and a decrease in the loss from operations of  in the st 
catharine s center which became a mobilexcimer site 
the european loss from operations decreased to  for the year ended april  from  for the year ended april  due to a decrease in the write down of lasers and related medical equipment of other income expense 
other income expense decreased to a net loss of  during the year ended april  from a net income of  during the year ended april  this decrease was due to a  decrease in interest income and other  a  increase in interest expense and a  decrease in the minority interest in the net loss of a subsidiary 
fiscal year ended april  compared to fiscal year ended april  during the year ended april   the company expanded its relationship with columbia in the us through the opening of five centers at columbia facilities  extended operation of its mobilexcimer system into a european market  opened two european centers  including a company owned center with an improved excimer laser system  began performing commercial prk procedures in the us market  completed three acquisitions one mobile laser service related  one expanding european operations and one expanding us marketing capabilities and closed five international fixed site centers which are now served by the mobilexcimer 
revenues 
total revenues increased to  for the year ended april  from  for the year ended april   or an increase of revenues for the laservision centers division increased slightly to  for the year ended april  from  for the year ended april  the slight increase in revenues is attributable to a  increase in us revenues and a  increase in canadian revenues  offset by a  decrease in european revenues 
the increase in us revenues for the laservision centers division is attributable primarily to the increased number of centers in operation and procedures performed in the us the decreased european revenues primarily related to a decreased number of fixed site centers and per procedure price fluctuations in europe 
revenues for the marketvision division increased to  for the year ended april  from  for the year ended april   or an increase of 
the  increase in marketvision division revenues reflects the acquisition of medsource in february and increased fees and commissions earned through the division s marketing and advertising activities 
during the year ended april   revenues from the laservision centers division represented of total revenues versus for the year ended april  revenues from the marketvision division represented of total revenues during the year ended april  versus for the year ended april  costs of revenues gross profit loss 
cost of revenues increased to  for the year ended april  from  for the year ended april  this increase was primarily due to an increase in depreciation to  from  in these respective periods due to the increased inventory of lasers and other medical equipment 
excluding laser and medical equipment depreciation  all other costs of revenues increased by  this increase  when combined with the revenue increase  resulted in these other costs of revenues increasing from of total revenues for the year ended april  to of total revenues for the year ended april  this  increase was primarily due to a  increase in marketvision costs associated with the increase in marketvision revenues and a  increase in total costs of excimer laser maintenance  gasses and optics on higher volumes of prk procedures and new centers 
total gross profit decreased to a loss of  for the year ended april  from a loss of  for the year ended april  the variable gross profit  excluding depreciation  increased to  from  primarily because marketvision costs of revenue are variable costs of revenue 
operating expenses 
general and administrative expenses increased to  for the year ended april  from  for the year ended april  due to a  increase in legal and professional fees  an  increase in the provision for bad debt  a  increase in the costs associated with developing the us market and  of expenses associated with opening a new center in europe  a  increase in insurance expenses and an increase of  in other general and administrative expenses 
the increase in salaries and related expenses to  for the year ended april  from  for the year ended april  was due to an increase of  attributable to an increased number of employees  salary adjustments and the related payroll taxes and fringe benefits  and an increase of  due to the executive incentive compensation program 
depreciation and amortization decreased by  for the year ended april  primarily due to the elimination of the amortization of previously deferred franchise costs of  partially offset by increased amortization of goodwill related to acquisitions of  and a net increase in depreciation of  the increase in selling and marketing expenses was due to an increase of  due to the promotion of the mobilexcimer  a  increase in european advertising program costs and  in initial development costs for the us market 
due to improvements in excimer laser technology  market conditions and the resulting operational considerations  the company believed that the recorded carrying value of certain of its assets exceeded their estimated fair values 
accordingly  the company recorded a non cash impairment charge of approximately million in the fourth quarter of fiscal loss from operations 
the laservision centers division s loss from operations increased to  for the year ended april  from  for the year ended april   primarily due to the provision for fixed asset impairment as discussed previously  increased costs related to commencing us operations  a  increase in total depreciation and amortization expenses  a  increase in variable costs of revenue and a  increase in operating costs 
the marketvision division s income from operations increased to  for the year ended april  from  for the year ended april  primarily as a result of the gross profit related to increased volume 
the domestic loss from operations increased to  for the year ended april  from  for the year ended april  due to a  increase in professional and legal fees  a  increase in the loss from us laser operations  a  increase in travel costs  a  increase in payroll and a  increase in other corporate overhead 
the canadian loss from operations increased to  for the year ended april  from  for the year ended april  primarily due to the write down of lasers and related medical equipment of  and an increase in the loss on operations of the mobile laser of  the european loss from operations increased to  for the year ended april  from  for the year ended april  due to the write down of lasers and related medical equipment of  a  decrease in gross profit due to declining revenues and increased depreciation and a  increase in overhead expenses 
other income expense 
other income expense increased to a net income of  during the year ended april  from a net expense of  during the year ended april  this favorable variance was due to an increase of  in interest income  a  increase in the minority interest in the net loss of a subsidiary and a decrease of  in interest expense 
inflation the company s operations have not been  nor are they expected to be  materially affected by inflation 
liquidity and capital resources since the completion of its initial public offering in april  the company s primary sources of liquidity have consisted of financing from the sale of common stock and convertible preferred stock  revenues from marketing and laser access services provided to ophthalmic physicians  leases and notes payable 
at april   the company had  of cash and cash equivalents compared with  at april  at april   the company had working capital of  compared with working capital of  at april  the ratio of current assets to current liabilities at april  was to one  compared to to one at april  cash flows from operating activities 
net cash used for operating activities was  for fiscal and was  and  for fiscal and  respectively 
the cash flows used for operating activities during fiscal primarily represent the net loss incurred in this period less depreciation  amortization and fixed asset impairment and an increase in accounts payable  offset by an increase in accounts receivable 
the cash flows used for operating activities in fiscal primarily represent the net loss incurred less depreciation  amortization and fixed asset impairment 
the cash flows used for operating activities in fiscal primarily represent the net loss incurred less depreciation and amortization 
cash flows from investing activities 
net cash used for investing activities was  during fiscal and  and  for fiscal and  respectively  and was primarily due to the acquisition of equipment  equipment deposits and acquisitions 
the increase in acquisitions of equipment in fiscal is primarily due to expansion into the us market and continued growth in the european market 
cash flows from financing activities 
net cash provided by financing activities during fiscal was  and was primarily due to proceeds received from notes payable and the exercise of stock options offset by the repayment of certain notes payable and capitalized lease obligations 
net cash provided by financing activities for fiscal was  and was primarily due to proceeds received from a private placement of the company s convertible preferred stock with a provision for mandatory redemption in and the exercise of warrants 
for fiscal  net cash provided by financing activities was  and was primarily due to proceeds received from the exercise of warrants and private stock offerings offset by the repayment of certain notes payable and capitalized lease obligations 
the company anticipates that its current cash and cash equivalents  together with the net proceeds of approximately million from the private placement completed in june  will be sufficient to fund operating expenses for the next two years  including any capital expenditures not financed by leasing 
the company expects to continue to fund future operations and mobile development costs from existing cash and cash equivalents  revenues received from providing laser access and market services  the exercise of stock options and warrants and future financing as required 
there can be no assurance that capital will be available when needed or  if available  that the terms for obtaining such funds will be favorable to the company 
new accounting standard in march  the financial standards board issued a statement of financial accounting standards no 
 earnings per share fas which requires public entities to present both basic and diluted earnings per share amounts on the face of their financial statements  replacing the former calculations of primary and fully diluted earnings per share 
the company will adopt fas effective with its fiscal third quarter and anticipates that when adopted  fas will not have a material effect on its reported earnings per common share 

